INSIGHTS ON CLINICAL TRIAL DESIGN
-
![Human Abuse Potential]( "Human Abuse Potential: Selecting A Positive Control")
Human Abuse Potential: Selecting A Positive ControlChoosing an effective positive control in HAP studies is critical but not always straightforward. Learn how to justify comparator and dose selection.
-
![Navigating Pediatrics]( "Navigating Pediatric Clinical Trials: Challenges And Specific Strategies For Success")
Navigating Pediatric Clinical Trials: Challenges And Specific Strategies For SuccessAdvance your understanding of pediatric therapeutics with experts who will help you to navigate the complexities of designing age-specific trials and overcome specimen collection obstacles.
-
![GettyImages-1585068774 patient doctor, clinical trial, data]( "The Role Of FDA Initiatives In Early-Phase Oncology Trials")
The Role Of FDA Initiatives In Early-Phase Oncology TrialsProject FrontRunner represents a paradigm shift in oncology drug development, championing earlier-line studies to bring novel treatments to patients sooner.
-
![GettyImages-1477214805-cancer-cell-targeted]( "Challenges That Derail Bladder Cancer Trials And How To Anticipate Them Earlier")
Challenges That Derail Bladder Cancer Trials And How To Anticipate Them EarlierFrom the rapid evolution of standard-of-care benchmarks to the logistical strain of procedure-heavy urology workflows, the path to a successful endpoint is filled with operational friction.
-
The New Era Of Project Optimus: Implications For Oncology9/10/2025
In this presentation, expert speakers bring the impact of Project Optimus to life through real-world case studies and practical examples.
-
Real-World Value Realized From DHTs In Clinical Trials10/22/2024
Explore four real-world examples of clinical trials that successfully integrated DHTs. Each case study highlights how DHTs impacted specific aspects of trial design.
-
Avoiding The Gotchas: RTSM Build Tips From A Seasoned PM3/25/2026
Small protocol details can create outsized challenges when definitions are unclear or when integrations aren’t planned early.
-
Retention Through Intention — Designing Truly Patient-Centric Trials2/4/2026
High drop-out rates threaten clinical trial integrity. Implementing decentralized solutions and proactive support strategies during protocol design can significantly improve patient enrollment and retention.
-
Where Clinical Trial Reimbursement Gets Complicated10/5/2026
Learn where participant reimbursement can break down in clinical trials and how clearer payment processes can reduce delays and unnecessary work for research sites.
CLINICAL TRIAL DESIGN SOLUTIONS
-
![Asia iStock-1190455899]( "The Asia Drug Development Advantage")
Avance Clinical has located its Asia hub operations in Seoul, South Korea which is highly regarded for its advanced technology and scientific and medical excellence.
-
![Doctor talking to patient-GettyImages-1330555438]( "Supporting Patients For Better Clinical Trials")
From our inception, Ergomed has been committed to enhancing the patient journey in clinical trials. Our unique Ergomed CARE™ approach revolutionizes trials by optimizing the patient experience. Designed to address and resolve issues proactively, this comprehensive approach supports and engages all stakeholders, leading to accelerated study start-up, improved patient recruitment and retention, and investigator engagement.
-
![Altasciences_Award-Winning Clinical Research Services For Early-Phase Drug Development]( "Award-Winning Clinical Research Services For Early-Phase Drug Development")
Explore the breadth of Altasciences’ expertise in clinical pharmacology studies, supporting regulatory submissions across a diverse range of therapeutic areas.
-
![Analgesic-Development-GettyImages-2154970177]( "Advancing Analgesic Development With Validated Pain Models")
Explore validated pain models and integrated early-phase services designed to characterize dose response, evaluate safety and efficacy, and support informed decisions in analgesic development.
-
![Eye Drop iStock-1182318206]( "Comprehensive Services For Ophthalmology Drug Development")
As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market.
